CLX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Clorox Co (CLX) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has mixed signals, with weak financial performance, neutral analyst ratings, and no significant positive catalysts. While it offers a steady dividend and is considered a defensive stock in volatile markets, the current valuation and lack of strong growth indicators suggest holding off on buying for now.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 80.717, signaling the stock is overbought. Moving averages are converging, suggesting indecision. Key resistance levels are at $124.888 and $128.734, while support levels are at $112.434 and $108.588.
Clorox is highlighted as a top dividend stock amid market volatility, appealing to income-focused investors. The company is acquiring GOJO Industries, which could improve its portfolio in the long term.
Financial performance in Q2 2026 shows declining revenue (-0.77% YoY), net income (-18.65% YoY), and EPS (-16.77% YoY). Gross margin also dropped by 1.81%. Analysts have neutral ratings with modest price target increases, and there are no significant hedge fund or insider trading trends.
In Q2 2026, Clorox reported a revenue decline of -0.77% YoY to $1.673 billion, net income dropped -18.65% YoY to $157 million, and EPS fell -16.77% YoY to $1.29. Gross margin decreased to 42.86%, down -1.81% YoY, indicating cost pressures.
Analyst sentiment is neutral, with most firms maintaining Hold or Neutral ratings. Price targets range from $108 to $132, reflecting limited upside potential. Analysts cite cost pressures and uncertain margin improvements as concerns.
